Clinical Trials for Synthekine

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Synthekine

Clinical Trials (3)

NCT06544330
A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease
PHASE1Recruiting
48 participants
Started: Apr 29, 2025 · Completed: Apr 30, 2041
3 conditions1 sponsor5 locations
NCT05665062
Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies
PHASE1Active, not recruiting
36 participants
Started: Apr 23, 2023 · Completed: Nov 30, 2026
7 conditions1 sponsor4 locations
NCT05098132
STK-012 Monotherapy and in Combination Therapy in Patients With Solid Tumors
PHASE1Recruiting
202 participants
Started: Jan 25, 2022 · Completed: Oct 31, 2027
13 conditions1 sponsor27 locations